W iSys: Overview of UW System I nnovation Potential Maliyakal - - PowerPoint PPT Presentation

▶
w isys overview of uw system i nnovation potential
SMART_READER_LITE
LIVE PREVIEW

W iSys: Overview of UW System I nnovation Potential Maliyakal - - PowerPoint PPT Presentation

Aug 28, 2023 504 likes •713 views

W iSys: Overview of UW System I nnovation Potential Maliyakal John & Beth Donley Technology Categories Exam ples of Cutting Edge I nnovations Revenue Potential New I nitiatives WiSys: Function Protection of federally

slide-1
SLIDE 1

Maliyakal John & Beth Donley

W iSys: Overview of UW System I nnovation Potential

  • Technology Categories
  • Exam ples of Cutting Edge I nnovations
  • Revenue Potential
  • New I nitiatives
slide-2
SLIDE 2

WiSys: Function

  • Protection of federally funded discoveries

and their commercialization

  • WiSys bears the cost of patenting and

licensing

  • All licensing income is shared with inventor,

campus, and UW System

slide-3
SLIDE 3

Summary of WiSys Intellectual property Activity

  • Total number of disclosures- 137
  • Participation by all 12 campuses
  • Current active cases- 54
  • Number of pending patent applications- 16
  • $$ spent on IP protection- $520k
  • Issued patents- 11
  • Licensed technologies-1
  • Start-up companies- 1
slide-4
SLIDE 4

Distribution of Disclosures from Campuses- March 2005

11 137 Total 2 Whitewater 1 Superior 22 Stout 1 11 Stevens Point 4 River Falls 2 Platteville 8 Parkside 2 3 Oshkosh 7 67 Milwaukee 1 7 La Crosse 1 Green Bay 9 Eau Claire

Pat Issued ** Disclosures* Campus

*Total disclosures ** includes issued and allowed

slide-5
SLIDE 5

Life Sci 37% Phys Sci 40%

Misc 23%

WiSys Technology Category Distribution- 2005

Total 137

slide-6
SLIDE 6

Electrical Mechanical 45% Material* 28% Software 27% Material*

  • Composition
  • Process

Total 53

WiSys Disclosures: Physical Sciences Categories 2005

slide-7
SLIDE 7

Pharmaceuticals * Med Devices Imaging ** 36%

WiSys Disclosures: Life Sciences Categories- 2005

Pharmaceuticals*

  • Therapeutic molecules
  • Diagnostics
  • Genes

Medical Imaging **

  • Devices
  • Procedures

64% Total 45

slide-8
SLIDE 8

UW System Technologies; Examples of Innovation

  • Broad range of technologies
  • Mix of cutting edge and traditional
slide-9
SLIDE 9

Brian Smith UW River Falls Winter hardy, superior plum

Prunus domestica: Lydecker

slide-10
SLIDE 10

Research reagent market

Cholesterol tagging agent for medical imaging David Lewis & Scott Hartel: UW Eau Claire

Fluorescent Dyes

slide-11
SLIDE 11

Charles Gibson:

UW Oshkosh: Nanostructured Metal Compacts

Anisometric morphology and preferred orientation

slide-12
SLIDE 12

Aileen Yingst: UW Green Bay: Wisconsin Space Grant Consortium

Microscopic Imager on Board the Mars Exploration Rover

slide-13
SLIDE 13

Sedative Effects Anxiolytic Drugs Without Anxiolytic Drugs Without

A Billion Dollar Idea from WiSys UW-Milwaukee

slide-14
SLIDE 14

NovaScan

  • First WiSys licensed start-up
  • William and Christopher Gregory-founders
  • Partnership with TechStar
  • Electronically image biological tissues
  • Detection and diagnosis of cancers
  • Reduces need for invasive biopsy
slide-15
SLIDE 15
  • Secure electronic message transmission
  • Jack Tan, UW Eau Claire
  • Collection of dissolved gases from ground water
  • Bryant Browne, UW Stevens Point
  • Anti-infective agents from Comptonia peregrina
  • Aaron Monte, UW La Crosse
  • Investment casting slurry composition
  • Dan McGuire, UW Whitewater
slide-16
SLIDE 16

UW Milwaukee GABA receptor binding Neurological diseases UW La Crosse Antimicrobials UW Eau Claire Fluorescent agents Medical imaging UW Green Bay GABA binding molecules UW Oshkosh Luminescent compounds UW River Falls Super capsaicin

Rational Drug Design: Time Tested Path to Pharmaceuticals

UW Platteville Polymer chemistry

Entrepreneurial Opportunity

slide-17
SLIDE 17

Therapeutics Med/Devices Imaging ** 37%

23% Total 35

Medical Imaging 12%

Therapeutics 33% Biotech Discovery 29%

Nutrition 14%

Diagnostics 12%

Total 222* Biotech Discovery 40% UW Milwaukee * Vit D or Stem cell not included UW Madison

Comparison of Research Trends: Madison and Milwaukee

slide-18
SLIDE 18

Trends overview

0.1% 23% 12% 0% 0.9% 10% 14% 0% 62% 14% 33% 23% 28% 22% 12% 37% 9% 31% 29% 40%

WARF % Revenue**

WARF % Licensed WARF %Dis UWM %Dis.

Biotech/Discov Med.Imaging Therapeutics Nutrition Diagnostics

* 1993 through 2002 ** ~$28million in 10yrs

Madison* and Milwaukee

slide-19
SLIDE 19

WiSys Initiatives to Achieve Greater Awareness WiSys Innovation Scholar Award-2005

  • Competitive selection of innovative discovery

from each campus

  • Publicity and local business participation
  • Small monetary award for research supplies
  • Pledges from local firms for “WiSys Scholar Fund”
slide-20
SLIDE 20
  • Quarterly Newsletter
  • Prototype Development Fund
  • WEN
  • Local business connection and tech transfer
  • Connect business needs to campus expertise
  • Student and worker high tech training
  • High-growth vision and plan based on UW System

innovation and resources

WiSys New Initiatives